Tempus AI (TEM) EV/EBIT: History & Chart

Tempus AI, Inc.(TEM)

Medical - Healthcare Information Services · Chicago, IL

$59.13-2.15 (-3.51%)

Delayed quote: Sep 10, 2026, 1:15 PM EDT

About Tempus AI, Inc.

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.

Chicago, IL

3,800 employees

www.tempus.com

Healthcare / Medical - Healthcare Information Services

Sector: Healthcare
Industry: Medical - Healthcare Information Services
CEO: Eric Lefkofsky

View full financials

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Tempus AI, Inc. (TEM)	$10.36B	N/A	N/A	N/A	N/A
Universal Health Services, Inc. (UHS)vs ›	$10.41B	7.55x	8.78x	11.25x	11.63x
Molina Healthcare, Inc. (MOH)vs ›	$10.42B	31.73x	12.65x	11.20x	12.41x
The Cooper Companies, Inc. (COO)vs ›	$10.50B	N/A	26.12x	30.95x	34.82x
The Ensign Group, Inc. (ENSG)vs ›	$10.04B	25.74x	30.44x	30.20x	26.91x
Align Technology, Inc. (ALGN)vs ›	$10.70B	17.61x	19.28x	24.31x	28.55x
Bio-Rad Laboratories, Inc. (BIO)vs ›	$10.00B	45.48x	39.54x	33.47x	33.07x
Globus Medical, Inc. (GMED)vs ›	$9.99B	14.69x	25.44x	55.50x	46.49x
Henry Schein, Inc. (HSIC)vs ›	$9.98B	17.62x	16.37x	16.63x	15.59x
Bio-Techne Corporation (TECH)vs ›	$11.31B	45.01x	77.55x	58.94x	57.75x

NAME

MARKET CAP

EV/EBIT RATIO

TTM

Tempus AI, Inc. (TEM)

$10.36B

N/A

Universal Health Services, Inc. (UHS)vs ›

$10.41B

7.55x

8.78x

11.25x

11.63x

Molina Healthcare, Inc. (MOH)vs ›

$10.42B

31.73x

12.65x

11.20x

12.41x

The Cooper Companies, Inc. (COO)vs ›

$10.50B

N/A

26.12x

30.95x

34.82x

The Ensign Group, Inc. (ENSG)vs ›

$10.04B

25.74x

30.44x

30.20x

26.91x

Align Technology, Inc. (ALGN)vs ›

$10.70B

17.61x

19.28x

24.31x

28.55x

Bio-Rad Laboratories, Inc. (BIO)vs ›

$10.00B

45.48x

39.54x

33.47x

33.07x

Globus Medical, Inc. (GMED)vs ›

$9.99B

14.69x

25.44x

55.50x

46.49x

Henry Schein, Inc. (HSIC)vs ›

$9.98B

17.62x

16.37x

16.63x

15.59x

Bio-Techne Corporation (TECH)vs ›

$11.31B

45.01x

77.55x

58.94x

57.75x

EV/EBIT Ratio: N/A

TEM EV/EBIT Ratio Metrics

TEM Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics